Literature DB >> 10821329

Separate systems for serotonin and leptin in appetite control.

J C Halford1, J E Blundell.   

Abstract

Appetite control involves an integration of the drive signals arising form energy stores in the body with the satiety signals generated by periodic episodes of food consumption. Serotonin (5-hydroxytryptamine, 5-HT) has been implicated in the processes of within-meal satiation and postmeal satiety (5-HT1B and 5-HT2C postsynaptic receptors) which are concerned with the signals arising form the pattern of food intake. Central nervous system (CNS) 5-HT is sensitive to circulating levels of the precursor tryptophan, certain macronutrients and peripheral satiety factors such as cholecystokinin (CCK) and enterostatin. Hypothalamic 5-HT receptor systems inhibit neuropeptide Y (NPY), a potent stimulator of hunger and food intake. In contrast to the linking of 5-HT with the consequences of food ingestion, the hormone leptin (OB protein) is regarded as a signal linking adipose tissue status with a number of key CNS circuits. Leptin itself stimulates CNS leptin receptors (OB-r receptor) which link with pro-opiomelanocortin (POMC)/ MC-4 receptors. The effects of leptin may also be modulated by factors such as the corticotrophin-releasing factor (CRF), cocaine and amphetamine-regulated transcript (CART), orexins and galanin. Very little evidence exists to support any direct link between the actions of 5-HT and leptin, suggesting that they are separate systems. 5-HT is a part of an integrated network for short-acting satiety signals (episodic in nature), and leptin is a hormonal indicator of long-term (tonic) energy reserves. At a conceptual level, these may represent the distinction between 'satiety' and 'drive'. Interestingly, both 5-HT and leptin modulate the action of NPY, which may form a part of a common output pathway for the expression of appetite.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821329     DOI: 10.3109/07853890008998829

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  28 in total

1.  Neonatal handling, sweet food ingestion and ectonucleotidase activities in nucleus accumbens at different ages.

Authors:  P P Silveira; G Cognato; L M Crema; F Q Pederiva; C D Bonan; J J Sarkis; A B Lucion; C Dalmaz
Journal:  Neurochem Res       Date:  2006-05-23       Impact factor: 3.996

Review 2.  A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.

Authors:  Jose M Palacios; Angel Pazos; Daniel Hoyer
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

Review 3.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Genetics of eating disorders.

Authors:  Anke Hinney; Anna-Lena Volckmar
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

5.  The chronic ingestion of diets containing different proteins produces marked variations in brain tryptophan levels and serotonin synthesis in the rat.

Authors:  SuJean Choi; Briana DiSilvio; Madelyn H Fernstrom; John D Fernstrom
Journal:  Neurochem Res       Date:  2011-01-05       Impact factor: 3.996

6.  Leptin and the GA genotype of rs2167270 of the LEP gene increase the risk of prediabetes.

Authors:  Mukhallad A Aljanabi; Mahmoud A Alfaqih; Mariam Khanfar; Zouhair O Amarin; Lina Elsalem; Rami Saadeh; Faheem Al-Mughales
Journal:  Biomed Rep       Date:  2021-03-09

7.  Acute tryptophan depletion and sweet food consumption by overweight adults.

Authors:  Sherry L Pagoto; Bonnie Spring; Dennis McChargue; Brian Hitsman; Malaina Smith; Bradley Appelhans; Donald Hedeker
Journal:  Eat Behav       Date:  2008-10-30

8.  The selective serotonin reuptake inhibitor paroxetine decreases breakpoint of rats engaging in a progressive ratio licking task for sucrose and quinine solutions.

Authors:  Clare M Mathes; Jillian R Gregson; Alan C Spector
Journal:  Chem Senses       Date:  2012-12-19       Impact factor: 3.160

9.  Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder.

Authors:  Adam Bisaga; Wojciech Danysz; Richard W Foltin
Journal:  Eur Neuropsychopharmacol       Date:  2008-06-24       Impact factor: 4.600

Review 10.  Eating disorders: the current status of molecular genetic research.

Authors:  Susann Scherag; Johannes Hebebrand; Anke Hinney
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-12-24       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.